Hemminki et al., found that participants with Type 1 (T1DM) and Type 2 DM (T2DM) (with or without insulin treatment) had a statistically significantly increased CUP risk compared to participants without DM [24]. The gene discussed is INS; the disease is type 2 diabetes mellitus.